183 related articles for article (PubMed ID: 10986346)
21. Spinal N-methyl-D-aspartate receptors and nociception-evoked release of primary afferent substance P.
Nazarian A; Gu G; Gracias NG; Wilkinson K; Hua XY; Vasko MR; Yaksh TL
Neuroscience; 2008 Mar; 152(1):119-27. PubMed ID: 18222611
[TBL] [Abstract][Full Text] [Related]
22. Potentiation of glutamatergic synaptic transmission by protein kinase C-mediated sensitization of TRPV1 at the first sensory synapse.
Sikand P; Premkumar LS
J Physiol; 2007 Jun; 581(Pt 2):631-47. PubMed ID: 17363391
[TBL] [Abstract][Full Text] [Related]
23. Heat hyperalgesia induced by endoneurial nerve growth factor and the expression of substance P in primary sensory neurons.
Ruiz G; Baños JE
Int J Neurosci; 2009; 119(2):185-203. PubMed ID: 19125373
[TBL] [Abstract][Full Text] [Related]
24. The spinal contribution of substance P to the generation and maintenance of inflammatory hyperalgesia in the rat.
Traub RJ
Pain; 1996 Sep; 67(1):151-161. PubMed ID: 8895243
[TBL] [Abstract][Full Text] [Related]
25. Time-course of the internalization and recycling of neurokinin 1 receptors in rat dorsal horn neurons.
Wang X; Marvizón JC
Brain Res; 2002 Jul; 944(1-2):239-47. PubMed ID: 12106686
[TBL] [Abstract][Full Text] [Related]
26. Acute thermal hyperalgesia in the rat is produced by activation of N-methyl-D-aspartate receptors and protein kinase C and production of nitric oxide.
Meller ST; Dykstra C; Gebhart GF
Neuroscience; 1996 Mar; 71(2):327-35. PubMed ID: 9053788
[TBL] [Abstract][Full Text] [Related]
27. The spinal antinociceptive mechanism determined by systemic administration of BD1047 in zymosan-induced hyperalgesia in rats.
Jeong YC; Son JS; Kwon YB
Brain Res Bull; 2015 Oct; 119(Pt A):93-100. PubMed ID: 26434709
[TBL] [Abstract][Full Text] [Related]
28. Supraspinal injection of Substance P attenuates allodynia and hyperalgesia in a rat model of inflammatory pain.
Parenti C; Aricò G; Ronsisvalle G; Scoto GM
Peptides; 2012 Apr; 34(2):412-8. PubMed ID: 22306475
[TBL] [Abstract][Full Text] [Related]
29. Spinal phospholipase A2 in inflammatory hyperalgesia: role of the small, secretory phospholipase A2.
Svensson CI; Lucas KK; Hua XY; Powell HC; Dennis EA; Yaksh TL
Neuroscience; 2005; 133(2):543-53. PubMed ID: 15885922
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of tonic spinal glutamatergic activity induces antinociception in the rat.
Tambeli CH; Parada CA; Levine JD; Gear RW
Eur J Neurosci; 2002 Oct; 16(8):1547-53. PubMed ID: 12405969
[TBL] [Abstract][Full Text] [Related]
31. Intracellular messengers contributing to persistent nociception and hyperalgesia induced by L-glutamate and substance P in the rat formalin pain model.
Coderre TJ; Yashpal K
Eur J Neurosci; 1994 Aug; 6(8):1328-34. PubMed ID: 7526941
[TBL] [Abstract][Full Text] [Related]
32. Clonidine depresses LTP of C-fiber evoked field potentials in spinal dorsal horn via NO-cGMP pathway.
Ge YX; Xin WJ; Hu NW; Zhang T; Xu JT; Liu XG
Brain Res; 2006 Nov; 1118(1):58-65. PubMed ID: 16950233
[TBL] [Abstract][Full Text] [Related]
33. NMDA and AMPA receptors contribute to the maintenance of substance P-induced thermal hyperalgesia.
Nakayama T; Naono R; Ikeda T; Nishimori T
Neurosci Res; 2010 May; 67(1):18-24. PubMed ID: 20096735
[TBL] [Abstract][Full Text] [Related]
34. Treatment with ketanserin produces opioid-mediated hypoalgesia in the late phase of carrageenan-induced inflammatory hyperalgesia in rats.
Huang J; Cai Q; Chen Y; Hong Y
Brain Res; 2009 Dec; 1303():39-47. PubMed ID: 19782054
[TBL] [Abstract][Full Text] [Related]
35. Decreased substance P and NK1 receptor immunoreactivity and function in the spinal cord dorsal horn of morphine-treated neonatal rats.
Thomson LM; Terman GW; Zeng J; Lowe J; Chavkin C; Hermes SM; Hegarty DM; Aicher SA
J Pain; 2008 Jan; 9(1):11-9. PubMed ID: 17950674
[TBL] [Abstract][Full Text] [Related]
36. A role for protein kinase intracellular messengers in substance P- and nociceptor afferent-mediated excitation and expression of the transcription factor Fos in rat dorsal horn neurons in vitro.
Badie-Mahdavi H; Worsley MA; Ackley MA; Asghar AU; Slack JR; King AE
Eur J Neurosci; 2001 Aug; 14(3):426-34. PubMed ID: 11553293
[TBL] [Abstract][Full Text] [Related]
37. Spinal PKC activity and expression: role in tolerance produced by continuous spinal morphine infusion.
Granados-Soto V; Kalcheva I; Hua XY; Newton A; Yaksh TL
Pain; 2000 Apr; 85(3):395-404. PubMed ID: 10781912
[TBL] [Abstract][Full Text] [Related]
38. Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38 MAPK in spinal microglia.
Hua XY; Svensson CI; Matsui T; Fitzsimmons B; Yaksh TL; Webb M
Eur J Neurosci; 2005 Nov; 22(10):2431-40. PubMed ID: 16307586
[TBL] [Abstract][Full Text] [Related]
39. NMDA-receptor regulation of substance P release from primary afferent nociceptors.
Liu H; Mantyh PW; Basbaum AI
Nature; 1997 Apr; 386(6626):721-4. PubMed ID: 9109489
[TBL] [Abstract][Full Text] [Related]
40. Examination of tonic nociceptive behavior using a method of substance P-receptor desensitization in the dorsal horn.
Holland LN; Goldstein BD
Pain; 1994 Mar; 56(3):339-346. PubMed ID: 7517516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
